Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Cory_Nicholas
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:developedBy |
regenerative cell therapies
|
| gptkbp:focusesOn |
gene therapy
neurological diseases |
| gptkbp:foundedBy |
gptkb:Arnold_Kriegstein
gptkb:Arturo_Alvarez-Buylla gptkb:Cory_Nicholas gptkb:John_Rubenstein |
| gptkbp:foundedYear |
2015
|
| gptkbp:headquartersLocation |
gptkb:San_Francisco,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Neurona Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investor |
gptkb:Sofinnova_Ventures
gptkb:UCSF_Foundation_Investment_Company gptkb:The_Column_Group |
| gptkbp:leadProduct |
gptkb:NRTX-1001
|
| gptkbp:target |
epilepsy
neurological disorders |
| gptkbp:technology |
human stem cell-derived neural cell therapy
|
| gptkbp:website |
https://www.neuronatherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Fabrizio_Bonanni
|
| gptkbp:bfsLayer |
6
|